Time to clozapine initiation in treatment-resistant schizophrenia in the United Arab Emirates: retrospective cohort study with international benchmarking
Background Clozapine is the only antipsychotic with demonstrated efficacy in treatment-resistant schizophrenia, but remains underutilised worldwide, with limited data from the Middle East and North Africa. Aims We examined clozapine initiation, delays and outcomes in a large United Arab Emirates (UAE) cohort. Method We...